TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
AUTL

Autolus Therapeutics plc

Healthcare · Biotechnology

1.90$ +4.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Autolus Therapeutics plc (AUTL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 46 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AUTL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.4 1.8 10 0.0 0.0 0.0 9.0 21 21 24 26 46 117
1.5 1.8 1.8 1.9 1.2 138 18 24 29 25 25 20 99
-1.1 -1.8 8.3 -1.9 -1.2 -138 -9.0 -3.5 -7.4 -1.0 1.7 25 18
32 25 31 37 40 51 27 27 28 36 21 28 113
11 16 18 22 27 67 30 30 36 36 40 41 153
43 39 47 59 68 103 56 58 64 71 61 69 266
-44 -41 -39 -59 -69 -241 -65 -61 -72 -72 -60 -44 -247
5.0 30 19 10 11 31 10 6.8 11 23 11 2.7 47
-46 -65 -53 -58 -82 -26 -68 -48 -79 -91 -71 -39 -279
0.0 12 0.0 0.1 0.0 1.5 2.2 0.4 0.5 -1.2 0.9 0.5 0.7
-46 -77 -53 -58 -82 -28 -70 -48 -79 -90 -72 -39 -280
-41 -33 -32 -44 -66 -74 -56 -43 -65 -66 -57 -34 -221

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?